Effects of oestradiol, zeranol or trenbolone acetate implants on puberty, reproduction and fertility in heifers.
(41/102)
The effects of anabolic agents on reproduction in beef heifers were determined by using 300 mg trenbolone acetate (TBA), 36 mg zeranol and 19 mg oestradiol-17 beta in a biodegradable pellet (1E: American Cyanamid, USA), or two such pellets (2E). On Day 1 of experiment, 81 Hereford x Friesian heifers (mean age = 84 +/- 1.2 days) were allocated at random to the following treatments: (1) controls (N = 15); (2) TBA (N = 15); (3) 1E (N = 12); (4) 2E (N = 15); (5) zeranol (N = 13); (6) TBA + 2E (N = 11). The 1 (1E), or 2 (2E) oestradiol implants were administered on Day 1 of the experiment only. Heifers assigned to receive TBA and zeranol were implanted on Days 1, 84, 168 and 252. Blood progesterone concentrations and oestrous activity were monitored from Days 137 and 200 respectively. Mean age (days) and weight (kg) at puberty (first ovulation), for heifers that reached puberty in Groups 1-6 respectively were 352 and 308, 419 and 356, 373 and 325, 381 and 331, 400 and 353, 423 and 383 [residual standard deviation (r.s.d.) = 43.8 and 39.4 for age and weight respectively]. Heifers in Group 4 were older (P less than 0.05), but not heavier (P greater than 0.05), while those in Groups 2 and 5 were both older (P less than 0.005) and heavier (P less than 0.005) than the controls at puberty. Age and weight at puberty were not different in heifers assigned to Groups 3 and 4, or to Groups 2 and 6. The proportion of heifers showing oestrus before puberty (prepubertal oestrus) were 3/15, 12/15, 6/12, 7/15, 10/13 and 11/11 in Groups 1-6 respectively. Heifers in Groups 2 and 5 had higher incidences of prepubertal oestrus than controls, while those in other treatment groups were not different. There was no treatment effect on the incidence of silent ovulations, but the incidence of non-ovulatory oestrus, after puberty, was increased from 4/48 in Group 1 to 26/40 (P less than 0.001), 15/56 (P less than 0.05) and 34/57 (P less than 0.001) in Groups 2, 4 and 5, respectively. Heifers in Group 6 had a higher incidence of non-ovulatory oestrus (P less than 0.05), but not of prepubertal oestrus, than did those in Group 2.(ABSTRACT TRUNCATED AT 400 WORDS) (+info)
Phytoestrogen alpha-zearalanol ameliorates memory impairment and neuronal DNA oxidation in ovariectomized mice.
(42/102)
The effect of zeranol on live weight gain, feed intake and carcass composition of steers during compensatory growth.
(44/102)
To evaluate the effect of zeranol implants in steers on compensatory ++growth, 80 steer calves (9 mo of age; 200 kg) were fed at two feeding levels (RO = 9.2 MJ ME/kg DM; R1 = 6.9 MJ ME/kg DM) for 119 d (Period 1). During Period 2, steers were full-fed to 400 kg BW with (Z1) or without (ZO) zeranol implants. Ten steers were slaughtered at the end of Period 1 to estimate carcass composition. Differences of 100 kg in BW were achieved by restriction in Period 1. Subsequent to restriction, cumulative ADG remained greater (P less than .05) up to the 24th wk of recuperation and implants increased (P less than .001) BW gain by 31% and 24% for RO and R1, respectively. The average daily energy intake (ME/W(.75) in Period 2 was similar for all treatments. Feed conversion was improved by 21.5% (P less than .05) by implants. At the end of Period 2 the R1ZO had 8.6 kg less muscle (P less than .001), 2.9 kg less bone (P less than .001) and 5.9 kg more fat (P less than .05) than the ROZO. In comparison, the carcasses of the implanted animals did not show significant differences (P greater than .05) due to restriction. Carcass daily gains were increased by previous restriction (P less than .01) and implants (P less than .05). Zeranol increased daily live weight gain and feed conversion in animals in continuous growth as well as in those observed in compensatory growth an tended to eliminate a tendency for higher content of fat in carcasses of nonimplanted animals making compensatory growth. (+info)
Effects of creep feeding, zeranol implants and breed type on beef production: I. Calf and cow performance.
(45/102)
A 2-yr study was conducted to evaluate the effects of a high-energy creep feed, preweaning zeranol implants and breed type on calf and cow performance. Two hundred calves sired by Brahman and Romana Red bulls out of Angus and Angus x Brown Swiss reciprocal crossbred (F1) dams were stratified by breed type and sex to three creep treatments: no creep feed (NC); long-term creep (LC), creep-fed from 56 to 210 d of age (weaning); and short-term creep (SC), creep-fed from 146 to 210 d of age. Alternate calves within sex, breed type and creep treatment were implanted with 36 mg of zeranol at an average of 56 d and reimplanted 90 d later. The LC and SC calves had heavier (P less than .001) 210-d weights than NC calves (264 and 257 vs 231 kg, respectively), and the LC calves were heavier (P less than .001) at 146 d than NC calves. The LC calves had higher (P less than .001) ADG from 118 to 210 d of age and higher 146 and 210-d condition scores than did NC calves. Pregnancy rate was not affected (P greater than .46) by creep treatment of calf. Zeranol implants increased (P less than .01) 146- and 210-d weights (184 vs 175 kg and 259 vs 243 kg) and ADG during all periods to weaning. Brahman-sired calves had higher (P less than .005) 146- and 210-d weaning weights and frame scores than Romana Red-sired calves.(ABSTRACT TRUNCATED AT 250 WORDS) (+info)
Effects of creep feeding, zeranol implants and breed type on beef production: II. Reproductive development and fat deposition in heifers.
(46/102)
Effects of preweaning creep feeding and zeranol implants on reproductive tract development and udder and s.c. fat deposition were studied in 24 weanling heifers (7 mo of age) with Brahman and Romana Red sires and Angus and Angus x Brown Swiss F1 reciprocal crossbred dams. Creep treatment did not affect (P greater than .19) ovarian weight, ovarian size, uterine horn diameter or follicle number. Heifers from the three creep treatments did not differ (P greater than .25) in udder weight, total lipid or percentage of lipid in the udder. Noncreep-fed (NC) heifers had a greater (P less than .02) number of adipocytes/gram of udder tissue than did the long-term creep-fed (LC) and short-term creep-fed (SC) heifers. The LC heifers had larger udder (166.0 vs 152.7 m) and s.c. adipocytes (166.7 vs 148.8 m) than NC heifers. Heifers implanted with zeranol at 56 and 146 d of age had a greater (P less than .03) uterine horn diameter and heavier (P less than .02) uterine weight than unimplanted heifers. Percentage of lipid in the udder was lower (P less than .02) in heifers implanted with zeranol. Implanted heifers had smaller (P less than .10) s.c. adipocytes than unimplanted heifers. Breed of dam did not effect (P greater than .17) development of the reproductive tract of weanling heifers. Heifers from Angus dams had smaller (P less than .08) udders and less (P less than .10) total fat in the udder than those from F1 dams, and the heifers from F1 dams tended (P less than .12) to have larger udder adipocytes.(ABSTRACT TRUNCATED AT 250 WORDS) (+info)
Growth and sexual characteristics of suckling beef calves as influenced by age at castration and growth implants.
(47/102)
A 2-yr study using crossbred male calves (n = 228) evaluated castrating at birth or at 4 mo of age and use of anabolic growth implants (none, zeranol or estradiol-17 beta). Angus, Hereford and Brahman crossbred calves produced in seven cow-calf units that varied by breed component, stocking rate and calving season were allotted to treatment at birth in a 2 x 3 factorial arrangement. Growth implants decreased (P less than .01) testicular weight and expression (P less than .05) of male secondary sex characteristics in suckling bull calves at 4 mo. Implanted calves were shorter (P less than .05) at the hips and had shorter front legs (P less than .01) at both 4 mo and at weaning. Cannon bone circumference at weaning was increased (P less than .05) by growth implants. Age at castration did not affect (P greater than .05) calf performance or body characteristics. Calves given growth implants had higher (P less than .05) rates of gain from birth to 4 mo than did nonimplanted calves (.75 vs .71 kg/d). Implanted calves were heavier (P less than .01) at weaning and had higher (P less than .01) ADG from 4 mo to weaning than did nonimplanted calves. These data indicate no benefit from delaying age at castration, but implanting increased weaning weight an average of 8.2 kg. (+info)
Occupational exposure to zeranol, an animal growth promoter.
(48/102)
Zeranol (3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2 - benzoxacyclotetradecin-1-one) is a synthetic oestrogenic agent used as an animal growth promoter. The effects of occupational exposure to zeranol in 11 exposed workers from a pelletising plant and 14 nonexposed subjects were assessed. A questionnaire showed that more breast symptoms were reported by male and female plant workers compared with non-exposed subjects, although the difference was not statistically significant. Clinical assessment showed no cases of gynaecomastia in all the male participants. Blood samples analysed by high performance liquid chromatography for zeranol, its precursor zearalenone, and its main metabolites did not show any of these compounds above the laboratory limit of detection. Serum levels of follicle stimulating hormone (FSH), luteinising hormone (LH), prolactin, and oestradiol showed no striking differences between the exposed and the non-exposed subjects. Total and low density lipoprotein cholesterol (LDL cholesterol) levels did not significantly differ between the two groups but mean high density lipoprotein cholesterol (HDL cholesterol) levels were higher in the exposed group; this could be due to relatively high HDL cholesterol in two women exposed to zeranol or relatively low HDL cholesterol in three non-exposed men. (+info)